JHIU
JAZZ icon

Janus Henderson Investors US’s Jazz Pharmaceuticals JAZZ Stock Holding History

Janus Henderson Investors US’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$213M Buy
1,470,245
+468,940
+47% +$61.1M 0.17% 163
2016
Q4 		$109M Buy
1,001,305
+21,681
+2% +$2.41M 0.09% 272
2016
Q3 		$119M Sell
979,624
-13,124
-1% -$1.77M 0.1% 260
2016
Q2 		$140M Sell
992,748
-181,729
-15% -$26.8M 0.12% 235
2016
Q1 		$153M Sell
1,174,477
-29,949
-2% -$3.73M 0.13% 203
2015
Q4 		$169M Buy
1,204,426
+135,668
+13% +$18.8M 0.14% 190
2015
Q3 		$142M Sell
1,068,758
-560,418
-34% -$96.5M 0.13% 207
2015
Q2 		$287M Sell
1,629,176
-364,797
-18% -$65.5M 0.24% 102
2015
Q1 		$345M Sell
1,993,973
-873,250
-30% -$150M 0.28% 87
2014
Q4 		$469M Sell
2,867,223
-320,907
-10% -$53.3M 0.4% 57
2014
Q3 		$512M Sell
3,188,130
-132,490
-4% -$20.4M 0.47% 45
2014
Q2 		$488M Buy
3,320,620
+414,338
+14% +$57.5M 0.45% 45
2014
Q1 		$403M Buy
2,906,282
+76,857
+3% +$11.6M 0.37% 65
2013
Q4 		$358M Sell
2,829,425
-557,316
-16% -$57.7M 0.34% 74
2013
Q3 		$311M Sell
3,386,741
-1,428,404
-30% -$115M 0.31% 83
2013
Q2 		$331M Buy
+4,815,145
New +$294M 0.35% 77

Other funds holding JAZZ

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Janus Henderson Investors US's JAZZ Position: Q1 2017 in Review

Janus Henderson Investors US increased its Jazz Pharmaceuticals (JAZZ) stake by 47% in Q1 2017, buying an estimated $61.1M and bringing the position to 1,470,245 shares worth $213M. The position accounts for 0.17% of the portfolio, ranked #163.

Janus Henderson Investors US first reported a position in JAZZ in Q2 2013 and has held it in 16 quarters since. The position peaked at $512M in Q3 2014. 306 funds tracked by Wall St. Rank hold JAZZ as of Q1 2017.

  • Janus Henderson Investors US held 1,470,245 shares of Jazz Pharmaceuticals worth $213M as of Q1 2017.
  • Janus Henderson Investors US bought 468,940 Jazz Pharmaceuticals shares in Q1 2017, an estimated $61.1M.
  • Jazz Pharmaceuticals made up 0.17% of Janus Henderson Investors US's portfolio in Q1 2017, its #163 holding.
  • Janus Henderson Investors US first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 16 quarters since.
  • Janus Henderson Investors US's Jazz Pharmaceuticals position peaked at $512M in Q3 2014.
  • 306 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.